Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05758909

Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
585 (estimated)
Sponsor
Fundación EPIC · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Evaluation of the safety and efficacy of early discharge (24 hours) after transfemoral transcatheter aortic prosthesis implantation (TAVI).

Detailed description

Evaluation of the safety and efficacy of early discharge (24 hours) after transfemoral transcatheter aortic prosthesis implantation (TAVI).

Conditions

Interventions

TypeNameDescription
DEVICETF TAVIFollow-up Observation of patients having received a TF-TAVI

Timeline

Start date
2023-04-04
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2023-03-08
Last updated
2025-12-19

Locations

13 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT05758909. Inclusion in this directory is not an endorsement.

Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation (NCT05758909) · Clinical Trials Directory